The European Society for Medical Oncology (ESMO) has announced today that the 2024 TAT Honorary Award is bestowed to Funda Meric-Bernstam, Chair of the Department of Investigational Cancer Therapeutics — the Phase I Program, Medical Director of the Institute for Personalized Cancer Therapy (IPCT), and The Nellie B. Connally Chair in Breast Cancer at MD Anderson Cancer Center, for her remarkable contributions to precision oncology.
She will deliver her award lecture “Implementing precision oncology: From genomics to ADCs” on Monday, 26 February at the ESMO TAT Congress 2024 in Paris.